(1) The transcription factor CCAAT-enhancer-binding protein delta (C/EBPδ) increased the IL-6 transcription in breast cancer cells [48] presumably by binding to one or both C/EBP binding sites within the IL-6 promoter region [49]. Here, CEBPD is linked to breast cancer.